"Cancer is a complex family of diseases primarily characterized by the accumulation of mutations in cells within multicellular organisms, leading to accelerated proliferation and aggressive competition over limited space and resources. This is coupled with a loss of DNA replication quality control mechanisms, creating genetically heterogeneous clonal lines within patients and even within individual tumors. Each of these clonal lines may respond differently to the same perturbations, making the system naturally resistant to drug therapies. Great progress has been made in identifying and deciphering the roles of driver mutations in individual genes, but the mechanisms of oncogenesis can only be truly understood in the context of the misregulation of dynamical processes in cells' underlying gene regulatory networks (GRNs). This dissertation discusses the topological and dynamical properties of GRNs in cancer, and is divided into four main chapters. First, the basic tools of modern complex network theory are introduced. These traditional tools as well as those developed by myself (set efficiency, interset efficiency, and nested communities) are crucial for understanding the intricate topological properties of GRNs, and later chapters recall these concepts. Second, the biology of gene regulation is discussed, and a method for disease-specific GRN reconstruction developed by our collaboration is presented. This complements the traditional exhaustive experimental approach of building GRNs edge-by-edge by quickly inferring the existence of as of yet undiscovered edges using correlations across sets of gene expression data. This method also provides insight into the distribution of common mutations across GRNs. Third, I demonstrate that the structures present in these reconstructed networks are strongly related to the evolutionary histories of their constituent genes. Investigation of how the forces of evolution shaped the topology of GRNs in multicellular organisms by growing outward from a core of ancient, conserved genes can shed light upon the "reverse evolution" of normal cells into unicellular-like cancer states. Next, I simulate the dynamics of the GRNs of cancer cells using the Hopfield model, an infinite range spin-glass model designed with the ability to encode Boolean data as attractor states. This attractor-driven approach facilitates the integration of gene expression data into predictive mathematical models. Perturbations representing therapeutic interventions are applied to sets of genes, and the resulting deviations from their attractor states are recorded, suggesting new potential drug targets for experimentation. Finally, I extend the Hopfield model to modular networks, cyclic attractors, and complex attractors, and apply these concepts to simulations of the cell cycle process. Futher development of these and other theoretical and computational tools is necessary to analyze the deluge of experimental data produced by modern and future biological high throughput methods."--Pages ii-iii.
Read
